SEC Form 4 · accession 0001140361-17-046221
aTYR PHARMA INC · LIFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
EcoR1 Capital Fund Qualified, L.P.
10% Owner
Period of report
Nov 8, 2017
Accepted (ET)
Dec 14, 2017 · 3:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001339970
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 1, 2017 | P | 4,879 | $5.05 | A | 3,198,420 | D | |
| Common Stock | Nov 1, 2017 | P | 24,728 | $4.80 | A | 3,223,148 | D | |
| Common Stock | Nov 8, 2017 | S | 1,070 | $4.30 | D | 3,222,078 | D | |
| Common Stock | Nov 9, 2017 | S | 5,819 | $4.1504 | D | 3,216,259 | D | |
| Common Stock | Nov 10, 2017 | S | 5,860 | $4.0008 | D | 3,210,399 | D | |
| Common Stock | Nov 13, 2017 | S | 1,083 | $3.95 | D | 3,209,316 | D |
Table II — derivative securities
No Table II lines on this filing.